These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7589648)

  • 1. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization.
    Licciardi FL; Liu HC; Rosenwaks Z
    Fertil Steril; 1995 Nov; 64(5):991-4. PubMed ID: 7589648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of day 3 estradiol on in vitro fertilization outcome.
    Smotrich DB; Widra EA; Gindoff PR; Levy MJ; Hall JL; Stillman RJ
    Fertil Steril; 1995 Dec; 64(6):1136-40. PubMed ID: 7589666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization.
    Karande V; Morris R; Rinehart J; Miller C; Rao R; Gleicher N
    Fertil Steril; 1997 May; 67(5):900-3. PubMed ID: 9130896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of baseline serum oestradiol in controlled ovarian hyperstimulation of women with unexplained infertility.
    Costello MF; Hughes GJ; Garrett DK; Steigrad SJ; Ekangaki A
    Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):69-74. PubMed ID: 11284650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.
    Loumaye E; Engrand P; Howles CM; O'Dea L
    Fertil Steril; 1997 May; 67(5):889-99. PubMed ID: 9130895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].
    Zhang Z; Zhang XH; He TY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1170-4. PubMed ID: 26677665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled ovarian hyperstimulation. Relationship of early serum E2 levels to the ultimate response of oocyte donors.
    Kavic S; Cohen MA; Sauer MV; Lindheim SR
    J Reprod Med; 2001 Jul; 46(7):637-40. PubMed ID: 11499183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist.
    Lyttle Schumacher BM; Mersereau JE; Steiner AZ
    Fertil Steril; 2018 Apr; 109(4):633-637. PubMed ID: 29605403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes.
    Palmerola KL; Rudick BJ; Lobo RA
    J Assist Reprod Genet; 2018 Sep; 35(9):1675-1682. PubMed ID: 29704227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of the high peak serum estradiol on the outcome of in vitro fertilization cycles].
    Carmona-Ruiz IO; Galache-Vega P; Santos-Haliscak R; Díaz-Spíndola P; Batiza-Reséndiz VA; Hernández-Ayup S
    Ginecol Obstet Mex; 2010 Oct; 78(10):553-8. PubMed ID: 21966773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy.
    Buyalos RP; Daneshmand S; Brzechffa PR
    Fertil Steril; 1997 Aug; 68(2):272-7. PubMed ID: 9240255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum estradiol level on the human chorionic gonadotrophin administration day and clinical outcome.
    Li X; Zeng C; Shang J; Wang S; Gao XL; Xue Q
    Chin Med J (Engl); 2019 May; 132(10):1194-1201. PubMed ID: 30973445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome.
    Papageorgiou T; Guibert J; Goffinet F; Patrat C; Fulla Y; Janssens Y; Zorn JR
    Hum Reprod; 2002 Nov; 17(11):2846-50. PubMed ID: 12407037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome.
    Moraloğlu Ö; Tonguc EA; Özel M; Özakşit G; Var T; Sarikaya E
    Arch Gynecol Obstet; 2012 Mar; 285(3):857-62. PubMed ID: 21938500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicle stimulating hormone levels on cycle day 3 predict ovulation stimulation response.
    Ebrahim A; Rienhardt G; Morris S; Kruger TF; Lombard CJ; Van der Merwe JP
    J Assist Reprod Genet; 1993 Feb; 10(2):130-6. PubMed ID: 8339016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.
    Seifer DB; Lambert-Messerlian G; Hogan JW; Gardiner AC; Blazar AS; Berk CA
    Fertil Steril; 1997 Jan; 67(1):110-4. PubMed ID: 8986693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.